Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane- (Q42797225)

From Wikidata
Jump to navigation Jump to search
scientific article published on 22 November 2010
edit
Language Label Description Also known as
English
Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-
scientific article published on 22 November 2010

    Statements

    Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane- (English)
    Jeffrey T Bagdanoff
    Michael S Donoviel
    Amr Nouraldeen
    Marianne Carlsen
    Theodore C Jessop
    James Tarver
    Saadat Aleem
    Haiming Zhang
    Lakmal Boteju
    Jill Hazelwood
    Jack Yan
    Mark Bednarz
    Suman Layek
    Iris B Owusu
    Suma Gopinathan
    Liam Moran
    Zhong Lai
    Jeff Kramer
    S David Kimball
    Padmaja Yalamanchili
    William E Heydorn
    Kenny S Frazier
    Barbara Brooks
    Philip Brown
    Alan Wilson
    William K Sonnenburg
    Alan Main
    Kenneth G Carson
    Tamas Oravecz
    David J Augeri
    22 November 2010
    8650-8662

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit